Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DEAF SMITH COUNTY HOSPITAL DISTRICT

NPI: 1568454403 · HEREFORD, TX 79045 · General Acute Care Hospital · NPI assigned 08/17/2005

$4.41M
Total Medicaid Paid
49,779
Total Claims
39,039
Beneficiaries
49
Codes Billed
2020-09
First Month
2024-12
Last Month

Provider Details

Authorized OfficialREINART, GREG (CEO)
NPI Enumeration Date08/17/2005

Related Entities

Other providers sharing the same authorized official: REINART, GREG

ProviderCityStateTotal Paid
DEAF SMITH COUNTY HOSPITAL DISTRICT HEREFORD TX $8.24M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 1,066 $109K
2021 12,899 $1.06M
2022 15,517 $1.31M
2023 12,554 $1.27M
2024 7,743 $651K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 9,647 5,396 $1.86M
99284 Emergency department visit for the evaluation and management, high severity 4,355 2,343 $1.69M
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 9,209 8,773 $233K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,694 1,625 $212K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,467 2,359 $114K
A0427 Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 196 164 $43K
99282 Emergency department visit for the evaluation and management, low to moderate severity 225 132 $33K
80053 Comprehensive metabolic panel 3,316 2,894 $29K
87634 309 297 $28K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 3,129 2,793 $23K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 500 467 $23K
A0425 Ground mileage, per statute mile 248 208 $22K
81003 6,548 4,555 $20K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 183 173 $14K
0202U Oncology (prostate), multianalyte, gene expression profiling 59 57 $11K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 295 280 $7K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 124 119 $5K
71045 Radiologic examination, chest; single view 52 48 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 141 140 $3K
CP007 81 67 $3K
36415 Collection of venous blood by venipuncture 4,502 3,781 $3K
71046 Radiologic examination, chest; 2 views 29 26 $3K
84443 Thyroid stimulating hormone (TSH) 486 471 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 13 13 $2K
0353U 53 50 $2K
86780 98 91 $2K
99238 Hospital discharge day management, 30 minutes or less 49 35 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 27 27 $1K
81025 102 95 $1K
83036 Hemoglobin; glycosylated (A1C) 436 434 $956.93
99460 15 14 $945.00
85027 200 180 $943.85
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 14 14 $647.91
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 14 14 $647.91
83690 77 69 $631.88
87086 Culture, bacterial; quantitative colony count, urine 102 95 $571.29
86803 29 27 $532.40
99001 29 28 $395.72
87340 29 27 $385.29
80061 Lipid panel 337 332 $381.01
81001 200 175 $339.17
86701 29 27 $331.65
82728 13 13 $278.99
87081 21 19 $163.21
85018 12 12 $59.42
83880 32 28 $53.78
82570 25 25 $14.18
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel 12 12 $0.17
36416 16 15 $0.00